GLP-1 pens and insulin in Cayman heat: what storage data show

Every peptide medicine a physician prescribes in the Cayman Islands, from insulin to semaglutide and tirzepatide, is a fragile molecule shipped into a hot climate. The Cayman Islands National Weather Service reports that the wet season, from mid-May through October, averages 84.6 °F (29.2 °C), with daily highs near 89.1 °F (31.7 °C)¹. The islands' record high, 95.5 °F (35.3 °C), was set on Grand Cayman on 21 July 2023, and on 13 of that July's 31 days temperatures climbed past the climatological maximums¹². The labels of the most widely used peptide pens set their room-temperature ceiling at 30 °C³⁴.

What the labels say: semaglutide and insulin

Novo Nordisk's US prescriber material for Ozempic (semaglutide) says: "Unused Ozempic® pens should always be stored in the refrigerator between 36° F to 46° F (2° C to 8° C)"³. After first use, "The opened pen can be stored either at room temperature between 59º F and 86º F (15º C to 30º C)" or in the refrigerator, and "patients must dispose of the pen after 56 days, even if there is still medicine left inside"³. It adds: "It is critical to never freeze Ozempic®", and advises patients to avoid "locations exposed to extreme temperatures, such as in a car"³.

For insulin, the US FDA's emergency guidance says vials and cartridges "may be left unrefrigerated at a temperature between 59°F and 86°F for up to 28 days and continue to work", and warns that "The longer insulin is exposed to extreme heat or cold, the less effective it becomes"⁴. It advises keeping insulin "away from direct heat and out of direct sunlight" and not using insulin that has been frozen⁴. The once-weekly insulin icodec pen may be kept below 86 °F for up to 12 weeks⁴.

What heat does to peptide drugs: the evidence

Peptide and protein drugs are chemically and physically fragile, and a long review in Pharmaceutical Research summarizes "the advances that have been made" in protein stabilization and formulation⁸. The clinical question is how much potency is lost at real tropical temperatures, and the two best-known insulin studies point in different directions.

In a 2009 study from India, insulin stored at 32 and 37 °C "showed 14-18 per cent decrease in potency" by day 28, and the authors concluded that "Improper storage of insulin decreases the potency and hence the pharmacological action of insulin"⁵. In a 2021 study, insulin was kept at the oscillating temperatures recorded in a refugee camp in northern Kenya, between 25 and 37 °C, for four weeks; high performance liquid chromatography showed "perfect conformity to pharmacopeia guidelines", and bioactivity was "identical" to refrigerated controls⁶. The authors concluded that insulin "can be stored at such oscillating ambient temperatures for the usual four-week period of use"⁶. The difference matters: daily swings that fall back toward 25 °C overnight are not the same as constant exposure at 32 to 37 °C.

Shipping: where the cold chain breaks

Every imported medicine spends time in transit, where temperature control is hardest to guarantee. In a 2023 US study of packages sent by mail, the evaluated packages "spent an average of 68.3% of transit time" outside the reference range of 68 to 77 °F, with recorded temperatures from 5.1 °F to 102.3 °F; three-day summer shipments spent more time out of range than next-business-day ones⁷. The World Health Organization's model guidance for time- and temperature-sensitive pharmaceutical products, published in 2011, sets out "the principal requirements for the safe storage and distribution" of such products for regulators, logisticians and pharmaceutical professionals⁹.

The Health Services Authority has described its own exposure. In 2023 it explained that about 75% of its drugs come from the UK, 10% from the US and 15% from Puerto Rico, the Caribbean and Latin America, and that substantial stock was ordered ahead of hurricane season¹⁰. Products bought online travel through less controlled routes. The Pan American Health Organization warned in March 2026 that GLP-1 medicines sold through unofficial channels, "including the internet and social media", risk being "falsified, unauthorized, or substandard"¹².

What Cayman Islands law requires

The Pharmacy Law, 1979 has storage and inspection rules that predate modern biologics but still apply¹¹. Section 18 requires all pharmaceuticals "held in store or dispensed from store" to be "adequately packaged and labelled", and where the Chief Medical Officer "is not satisfied with the packing, storage or labelling of any poison or pharmaceutical he shall give instructions for the rectification thereof"; failing to comply is an offence¹¹. Section 17 opens all places used to store restricted pharmaceuticals to inspection by the Chief Medical Officer "at all reasonable times"¹¹. The law sets no temperature standard of its own¹¹.